Signifier Medical Technologies Closes an Oversubscribed Series B Funding Round; Driving Innovation in the Sleep Market

snoozeal product controller and main product

LONDON, 17 June 2019
– Signifier Medical Technologies, previously known as Snoozeal, an innovator in the sleep disordered breathing market, today announced it has closed an oversubscribed Series B funding, aiming to invest further in R&D and prepare the company for commercial stage. With this round, Signifier Medical Technologies has raised a total in excess of $13 million since its founding in 2015.

Read the article in full on prnewswire.com

Take your first steps towards a restful night’s sleep today